SCHEMBL30747451

SCHEMBL30747451

COc1cc2nc(C)oc2cc1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.40
CSF1R P07333 1/20 0.36
ELANE P08246 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
GAA P10253 2/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32
SNCA P37840 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALOX5 P09917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24165260 1.00 EGFR (0.40) EGFRCSF1RELANELMNARAB9A
SCHEMBL28705520 0.86 EGFR (0.33) EGFRGAACHRNB2CHRNA4L3MBTL1
SCHEMBL25291405 0.83 EGFR (0.39) EGFRCSF1RLMNAGAASNCA
SCHEMBL16841344 0.82 L3MBTL1 (0.36) RAB9AGAACHRNB2CHRNA4L3MBTL1
SCHEMBL25251644 0.82 EGFR (0.40) EGFRCSF1RLMNARAB9ASNCA
SCHEMBL25251719 0.81 EGFR (0.37) EGFRCSF1RLMNARAB9AGAA
SCHEMBL720776 0.80 L3MBTL1 (0.35) LMNARAB9AGAACHRNB2CHRNA4
SCHEMBL29642075 0.80 L3MBTL1 (0.35) LMNARAB9AGAACHRNB2CHRNA4
SCHEMBL25248769 0.79 EGFR (0.36) EGFR
SCHEMBL24746247 0.77 L3MBTL1 (0.35) RAB9AGAACHRNB2CHRNA4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539841-A2 HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC Therapeutics, Inc. (US) 2025-04-23 EP disclosed
WO-2024182747-A2 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2024-09-06 WO disclosed
WO-2023244996-A2 HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE PTC THERAPEUTICS, INC. (US) 2023-12-21 WO disclosed